Inventor

YUE EDDY W

US67 patents

⚠️ This page may combine multiple inventors who share the name “YUE EDDY W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

YUE EDDY W

INCYTE CORP

Heterocyclylamines as PI3K inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Modulators of indoleamine 2,3-dioxygenase and methods of using the same

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

Heterocyclylamines as PI3K inhibitors

Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors

Tricyclic heterocycles as BET protein inhibitors

Bicyclic heterocycles as bet protein inhibitors

Heterocyclylamines as PI3K inhibitors

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors

Bicyclic heterocycles as BET protein inhibitors

Tricyclic heterocycles as BET protein inhibitors

Heterocyclylamines as PI3K inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Modulators of indoleamine 2,3-dioxygenase and methods of using the same

Modulators of indoleamine 2,3-dioxygenase and methods of using the same for treating cancer

Heterocyclic compounds as PI3K-γ inhibitors

Heterocyclylamines as PI3K inhibitors

Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors

Tertiary alcohols as PI3K-γ inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors

Heterocyclic compounds as PI3K-γ inhibitors

1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Modulators of indoleamine 2,3-dioxygenase and methods of using the same

Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disorders

Tricyclic urea compounds as JAK2 V617F inhibitors

Tertiary alcohols as PI3K-γ inhibitors

Heterocyclylamines as PI3K inhibitors

Tertiary alcohols as PI3K-γ inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor

COMBS ANDREW P

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Substituted heteroaryl fused derivatives as PI3K inhibitors

Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors

Fused derivatives as PI3Kδ inhibitors

Pyrimidine-4,6-diamine derivatives as PI3K inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

LI YUN-LONG

Heterocyclylamines as PI3K inhibitors

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors

BRISTOL MYERS SQUIBB PHARMA CO

Indeno [1,2-c] pyrazol-4-ones and their uses

Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use

DU PONT PHARM CO

Acylsemicarbazides and their uses

COMBS ANDREW PAUL

Macrocyclic compounds and their use as kinase inhibitors